RA Capital Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

RA Capital Management’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-417,476	Closed	-$1.97M	–	70
2015 Q1	$1.97M	Hold	417,476	–	–	0.2%	40
2014 Q4	$2.66M	Hold	417,476	–	–	0.29%	34
2014 Q3	$2.05M	Sell	417,476 -73,221	-15%	-$423K	0.24%	29
2014 Q2	$3.75M	Sell	490,697 -37,100	-7%	-$296K	0.38%	24
2014 Q1	$5.57M	Sell	527,797 -133,899	-20%	-$1.91M	0.4%	30
2013 Q4	$8.6M	Buy	661,696 +445,697	+206%	+$4.16M	1%	24
2013 Q3	$1.83M	Sell	215,999 -9,001	-4%	-$72.6K	0.19%	37
2013 Q2	$1.27M	Buy	+225,000	New	+$1.4M	0.17%	28

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

RA Capital Management's OCRX Position: Q2 2015 in Review

RA Capital Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q2 2015, closing a stake of 417,476 shares — an estimated $1.97M sold.

RA Capital Management first reported a position in OCRX in Q2 2013 and held it in 8 quarters. The position peaked at $8.6M in Q4 2013. 32 funds tracked by Wall St. Rank hold OCRX as of Q2 2015.

RA Capital Management reported no remaining Ocera Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
RA Capital Management sold 417,476 Ocera Therapeutics, Inc. shares in Q2 2015, an estimated $1.97M.
RA Capital Management first reported a position in Ocera Therapeutics, Inc. in Q2 2013 and held it in 8 quarters.
RA Capital Management's Ocera Therapeutics, Inc. position peaked at $8.6M in Q4 2013.
32 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q2 2015.

Based on RA Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.